The Gemini Brief - Investment Deep Dives podcast

AbbVie: a pharma giant navigating its defining transition (ABBV)

0:00
52:03
15 Sekunden vorwärts
15 Sekunden vorwärts
Slide Deck AbbVie has executed what may be the most successful franchise replacement in pharmaceutical history. The company’s combined Skyrizi and Rinvoq revenues reached $25.9 billion in 2025 — surpassing Humira’s all-time peak of $21.2 billion — while Humira itself declined to $4.5 billion from that peak. Total revenue hit a record $61.2 billion in […]

Weitere Episoden von „The Gemini Brief - Investment Deep Dives“